The heart-brain connection: Mechanistic insights and models

Netherlands Heart Journal

Volumn 21, Issue 2, 2013, Pages 55-57

  Ritz, K ^a   van Buchem, M A ^b   Daemen, M J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiovascular dysfunction; Cerebral hypoperfusion; Cognitive decline; Heart and brain; Neurodegeneration

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CYCLOPHILIN A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; ATHEROSCLEROSIS; AUTOREGULATION; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN PERFUSION; CARDIOVASCULAR DISEASE; CELL INFILTRATION; COGNITIVE DEFECT; CORONARY ARTERY BYPASS GRAFT; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PREVALENCE; VASOMOTOR REFLEX;

EID: 84875194517     PISSN: 15685888     EISSN: 18766250     Source Type: Journal    
DOI: 10.1007/s12471-012-0348-9     Document Type: Article

References (41)

1. Iadecola C, Nedergaard M. Glial regulation of the cerebral microvasculature. Nat Neurosci. 2007;10:1369-1376.
2. Paulson OB, Hasselbalch SG, Rostrup E, et al. Cerebral blood flow response to functional activation. J Cereb Blood Flow Metab. 2010;30:2-14.
3. van Beek AH, Claassen JA, Rikkert MG, et al. Cerebral autoregulation: an overview of current concepts and methodology with special focus on the elderly. J Cereb Blood Flow Metab. 2008;28:1071-1085.
4. Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron. 2010;67:181-198.
5. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42:2672-2713.
6. Paulson OB, Jarden JO, Godtfredsen J, et al. Cerebral blood-flow in patients with congestive heart-failure treated with captopril. Am J Med. 1984;76:91-95.
7. Choi BR, Kim JS, Yang YJ, et al. Factors associated with decreased cerebral blood flow in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol. 2006;97:1365-1369.
8. Jefferson AL, Himali JJ, Au R, et al. Relation of left ventricular ejection fraction to cognitive aging (from the Framingham heart study). Am J Cardiol. 2011;108:1346-1351.
9. Roman DD, Kubo SH, Ormaza S, et al. Memory improvement following cardiac transplantation. J Clin Exp Neuropsychol. 1997;19:692-697.
10. Dixit NK, Vazquez LD, Cross NJ, et al. Cardiac resynchronization therapy: a pilot study examining cognitive change in patients before and after treatment. Clin Cardiol. 2010;33:84-88.
11. Petrucci RJ, Rogers JG, Blue L, et al. Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatileflow left ventricular assist device support. J Heart Lung Transplant. 2012;31:27-36.
12. Tranmer BI, Keller TS, Kindt GW, et al. Loss of cerebral regulation during cardiac output variations in focal cerebral ischemia. J Neurosurg. 1992;77:253-9.
13. Bakker FC, Klijn CJ, Jennekens-Schinkel A, et al. Cognitive impairment in patients with carotid artery occlusion and ipsilateral transient ischemic attacks. J Neurol. 2003;250:1340-1347.
14. Bakker FC, Klijn CJ, van der Grond J, et al. Cognition and quality of life in patients with carotid artery occlusion: a follow-up study. Neurology. 2004;62:2230-2235.
15. Bakker FC, Klijn CJ, Jennekens-Schinkel A, et al. Cognitive impairment is related to cerebral lactate in patients with carotid artery occlusion and ipsilateral transient ischemic attacks. Stroke. 2003;34:1419-1424.
16. Goto T, Baba T, Honma K, et al. Magnetic resonance imaging findings and postoperative neurologic dysfunction in elderly patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 2001;72:137-142.
17. Selnes OA, Gottesman RF, Grega MA, et al. Cognitive and neurologic outcomes after coronary-artery bypass surgery. New Engl J Med. 2012;366:250-257.
18. Bos D, van der Rijk MJM, Geeraedts TEA, et al. Intracranial carotid artery atherosclerosis prevalence and risk factors in the general population. Stroke. 2012;43:1878-1884.
19. Bos D, Ikram MA, Elias-Smale SE, et al. Calcification in major vessel beds relates to vascular brain disease. Arterioscler Thromb Vasc Biol. 2011;31:2331-2337.
20. Bos D, Vernooij MW, Elias-Smale SE, et al. Atherosclerotic calcification relates to cognitive function and to brain changes on magnetic resonance imaging. Alzheimers Dement. 2012.
21. Shibata M, Ohtani R, Ihara M, et al. White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke. 2004;35:2598-2603.
22. Shibata M, Yamasaki N, Miyakawa T, et al. Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke. 2007;38:2826-2832.
23. Fujita Y, Ihara M, Ushiki T, et al. Early protective effect of bone marrow mononuclear cells against ischemic white matter damage through augmentation of cerebral blood flow. Stroke. 2010;41: 2938-2943.
24. Nishio K, Ihara M, Yamasaki N, et al. A mouse model characterizing features of vascular dementia with hippocampal atrophy. Stroke. 2010;41:1278-1284.
25. Coltman R, Spain A, Tsenkina Y, et al. Selective white matter pathology induces a specific impairment in spatial working memory. Neurobiol Aging. 2011;32.
26. Nakamura A, Rokosh DG, Paccanaro M, et al. LV systolic performance improves with development of hypertrophy after transverse aortic constriction in mice. Am J Physiol Heart Circ Physiol. 2001;281:H1104-H1112.
27. Chintalgattu V, Ai D, Langley RR, et al. Cardiomyocyte PDGFRbeta signaling is an essential component of the mouse cardiac response to load-induced stress. J Clin Invest. 2010;120:472-484.
28. Poulet R, Gentile MT, Vecchione C, et al. Acute hypertension induces oxidative stress in brain tissues. J Cerebral Blood Flow Metab. 2006;26:253-262.
29. Carnevale D, Mascio G, Ajmone-Cat MA, et al. Role of neuroinflammation in hypertension-induced brain amyloid pathology. Neurobiol Aging. 2012;33.
30. Gentile MT, Poulet R, Di Pardo A, et al. Beta-amyloid deposition in brain is enhanced in mouse models of arterial hypertension. Neurobiol Aging. 2009;30:222-228.
31. Carnevale D, Mascio G, D'Andrea I, et al. Hypertension induces brain beta-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature. Hypertension. 2012;60:188-197.
32. Okamoto Y, Yamamoto T, Kalaria RN, et al. Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts. Acta Neuropathol. 2012;123:381-394.
33. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57:178-201.
34. Marchesi C, Paradis P, Schiffrin EL. Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol Sci. 2008;29:367-374.
35. Gill R, Tsung A, Billiar T. Linking oxidative stress to inflammation: toll-like receptors. Free Radic Biol Med. 2010;48: 1121-1132.
36. Sim FJ, Zhao C, Penderis J, et al. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J Neurosci. 2002;22:2451-2459.
37. Simpson JE, Fernando MS, Clark L, et al. White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol Appl Neurobiol. 2007;33:410-419.
38. Arai K, Lo EH. Astrocytes protect oligodendrocyte precursor cells via MEK/ERK and PI3K/Akt signaling. J Neurosci Res. 2010;88:758-763.
39. Savva GM, Wharton SB, Ince PG, et al. Age, neuropathology, and dementia. New Engl J Med. 2009;360:2302-2309.
40. Armulik A, Genove G, Mae M, et al. Pericytes regulate the blood brain barrier. Nature. 2010;468:557-U231.
41. Bell RD, Winkler EA, Singh I, et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature. 2012;485:512-516.